Department of General Pediatrics and Neonatology, Saarland University Medical Center, Kirrberger Str., Building 9, 66421, Homburg, Germany.
Department of Pediatric Cardiology, Saarland University Medical Center, Homburg, Germany.
Wien Med Wochenschr. 2023 May;173(7-8):161-167. doi: 10.1007/s10354-022-00952-z. Epub 2022 Aug 8.
Umbilical venous catheters (UVC) and peripherally inserted central catheters (PICC) are commonly used in preterm infants but have been associated with a number of serious complications. We performed a survey in Austria and Germany to assess the use of UVCs and PICCs in preterm infants with a birth weight < 1250 g and associated rates of catheter-related adverse events.
Electronic survey of participating centers of the NeoVitaA trial. Main outcome parameter was the reported rates of UVC- and PICC-associated complications (infection, thrombosis, emboli, organ injury, arrhythmia, dislocation, miscellaneous).
In total, 20 neonatal intensive care units (NICU) providing maximal intensive care in Austria and Germany (level I) were contacted, with a senior neonatologist response rate of 12/20 (60%). The reported rates for UVC with a dwell time of 1-10 days were bacterial infection: 4.2 ± 3.4% (range 0-10%); thrombosis: 7.3 ± 7.1% (0-20%); emboli: 0.9 ± 2.0% (0-5%); organ injury: 1.1 ± 1.9% (0-5%); cardiac arrhythmia: 2.2 ± 2.5% (0-5%); and dislocation: 5.4 ± 8.7% (0-30%); and for PICCs with a dwell time of 1-14 days bacterial infection: 15.0 ± 3.4% (range 2.5-30%); thrombosis; 4.3 ± 3.5% (0-10%); emboli: 0.8 ± 1.6% (0-5%); organ injury: 1.5 ± 2.3% (0-5%); cardiac arrhythmia: 1.5 ± 2.3% (0-5%), and dislocation: 8.5 ± 4.6% (0-30%).
The catheter-related complication rates reported in this survey differed between UVCs and PICCs and were higher than those reported in the literature. To generate more reliable data on this clinically important issue, we plan to perform a large prospective multicenter randomized controlled trial investigating the non-inferiority of a prolonged UVC dwell time (up to 10 days) against the early change (up to 5 days) to a PICC.
脐静脉导管(UVC)和外周中心静脉导管(PICC)在早产儿中广泛使用,但与多种严重并发症相关。我们在奥地利和德国进行了一项调查,以评估出生体重<1250g 的早产儿中 UVC 和 PICC 的使用情况以及与导管相关的不良事件的发生率。
对 NeoVitaA 试验的参与中心进行电子调查。主要观察指标为 UVC 和 PICC 相关并发症(感染、血栓形成、栓塞、器官损伤、心律失常、脱位、其他)的报告发生率。
共联系了奥地利和德国 20 家提供最大强化护理的新生儿重症监护病房(NICU)(I 级),其中 12/20(60%)的高级新生儿科医生做出了回应。UVC 留置时间为 1-10 天的报告发生率为:细菌感染:4.2±3.4%(0-10%);血栓形成:7.3±7.1%(0-20%);栓塞:0.9±2.0%(0-5%);器官损伤:1.1±1.9%(0-5%);心律失常:2.2±2.5%(0-5%);脱位:5.4±8.7%(0-30%);PICC 留置时间为 1-14 天的报告发生率为:细菌感染:15.0±3.4%(2.5-30%);血栓形成:4.3±3.5%(0-10%);栓塞:0.8±1.6%(0-5%);器官损伤:1.5±2.3%(0-5%);心律失常:1.5±2.3%(0-5%);脱位:8.5±4.6%(0-30%)。
本调查中报告的导管相关并发症发生率在 UVC 和 PICC 之间存在差异,且高于文献报道。为了在这一具有重要临床意义的问题上获得更可靠的数据,我们计划开展一项大型前瞻性多中心随机对照试验,以研究延长 UVC 留置时间(最长 10 天)与早期更换为 PICC(最长 5 天)相比的非劣效性。